Syneron Medical Ltd. (ELOS) - Product Pipeline Analysis, 2016 Update

Market: Medical Devices

Israel, 32 pages report, published by GlobalData

Keywords : Syneron Medical Ltd., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Report ThumbnailJune-2016
Summary

Syneron Medical Ltd. (Syneron) is an aesthetic device company that designs, develops and markets aesthetic medical products. Its products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of leg veins, acne treatment, wrinkle reduction, hair removal, skin rejuvenation of the skin’s appearance, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and a minimally invasive product for laser-assisted lipolysis. Syneron utilizes various technologies including its proprietary Electro-Optical Synergy (ELOS) technology to develop aesthetic medical products. It sells products through a network of distributors and subsidiaries located in the US, Canada, Israel, Spain, France, Germany, Italy, the UK, China, Hong Kong, Japan and Australia. Syneron is headquartered in Yokneam Illit, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Syneron Medical Ltd.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • List of Figures
  • Syneron Medical Ltd. Pipeline Products by Equipment Type 8
  • Syneron Medical Ltd. Pipeline Products by Development Stage 13
  • Syneron Medical Ltd. Clinical Trials by Trial Status 14
  • List of Tables
  • Syneron Medical Ltd. Pipeline Products and Clinical Trials Overview 7
  • Syneron Medical Ltd. Pipeline Products by Equipment Type 7
  • Syneron Medical Ltd. Pipeline Products by Indication 8
  • Syneron Medical Ltd. Clinical Trials by Trial Status 8
  • Syneron Medical Ltd., Key Facts 10
  • Syneron Medical Ltd., Major Products and Services 11
  • Syneron Medical Ltd. Number of Pipeline Products by Development Stage 13
  • Syneron Medical Ltd. Pipeline Products Summary by Development Stage 13
  • Syneron Medical Ltd. Clinical Trials by Trial Status 14
  • Syneron Medical Ltd. Clinical Trials Summary 15
  • Pneumatic Skin Fattening (PSF) for Pigmented Lesions - Product Status 16
  • Pneumatic Skin Fattening (PSF) for Pigmented Lesions - Product Description 16
  • Pneumatic Skin Fattening (PSF) for Skin Toning - Product Status 17
  • Pneumatic Skin Fattening (PSF) for Skin Toning - Product Description 17
  • Pneumatic Skin Fattening For Telangectasia - Product Status 18
  • Pneumatic Skin Fattening For Telangectasia - Product Description 18
  • Ultrashape - Additional Body Areas - Product Status 19
  • Ultrashape - Additional Body Areas - Product Description 19
  • Ultrashape - Additional Body Areas - Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-invasive Abdominal Fat Reduction 20
  • Ultrashape - Additional Body Areas - Clinical Study to Evaluate the Safety and Efficacy of the Ultrashape Power Device Using the U-sculpt Power Transducer for Abdominal Fat and Circumference Reduction 20
  • Syneron Medical Ltd., Key Employees 22
  • Syneron Medical Ltd., Key Employee Biographies 23
  • Syneron Medical Ltd., Subsidiaries 24
  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 5
  • Syneron Medical Ltd. Company Snapshot 6
  • Syneron Medical Ltd. Company Overview 6
  • Syneron Medical Ltd. Pipeline Products and Clinical Trials Overview 7
  • Syneron Medical Ltd. – Pipeline Analysis Overview 9
  • Business Description 9
  • Key Facts 10
  • Syneron Medical Ltd. - Major Products and Services 11
  • Syneron Medical Ltd. Pipeline Products by Development Stage 13
  • Syneron Medical Ltd. Clinical Trials by Trial Status 14
  • Syneron Medical Ltd. Pipeline Products Overview 16
  • Pneumatic Skin Fattening (PSF) for Pigmented Lesions 16
  • Pneumatic Skin Fattening (PSF) for Pigmented Lesions Product Overview 16
  • Pneumatic Skin Fattening (PSF) for Skin Toning 17
  • Pneumatic Skin Fattening (PSF) for Skin Toning Product Overview 17
  • Pneumatic Skin Fattening For Telangectasia 18
  • Pneumatic Skin Fattening For Telangectasia Product Overview 18
  • Ultrashape - Additional Body Areas 19
  • Ultrashape - Additional Body Areas Product Overview 19
  • Ultrashape - Additional Body Areas Clinical Trial 20
  • Syneron Medical Ltd. - Key Competitors 21
  • Syneron Medical Ltd. - Key Employees 22
  • Syneron Medical Ltd. - Key Employee Biographies 23
  • Syneron Medical Ltd. - Locations And Subsidiaries 24
  • Head Office 24
  • Other Locations & Subsidiaries 24
  • Recent Developments 26
  • Syneron Medical Ltd., Recent Developments 26
  • May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million 26
  • Mar 03, 2016: Syneron Candela to Introduce the new CO2RE Intima at the 2016 American Academy of Dermatology Annual Meeting 27
  • Mar 03, 2016: Syneron Candela to Introduce SubQ Profound Applicator at the 2016 American Academy of Dermatology Annual Meeting 27
  • Mar 03, 2016: Syneron Candela to Introduce Ultra-Short PicoWay Laser at the 2016 American Academy of Dermatology Annual Meeting 27
  • Feb 22, 2016: Syneron Medical Reports Record Fourth Quarter 2015 Revenue of $78.9 Million 28
  • Jan 11, 2016: Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue 29
  • Nov 11, 2015: Syneron Medical Appoints Jeff Nardoci as President of North America Body Shaping Group 30
  • Nov 05, 2015: Syneron Candela Announces New FDA Clearance for the CO2RE System 30
  • Nov 04, 2015: Syneron Candela Unveils Radiofrequency Treatment Technology That Targets the Effects of Aging Skin 31
  • Oct 08, 2015: Syneron Candela Announces the Launch of PicoWay Resolve at EADV 31
  • Appendix 32
  • Methodology 32
  • About GlobalData 32
  • Contact Us 32
  • Disclaimer 32

Please select a license type

Share

Related Products

GlobalDataSyneron Medical Ltd. (ELOS) - Product Pipeline Analysis, 2016 UpdateProduct ThumbnailSyneron Medical Ltd. (ELOS) - Product Pipeline Analysis, 2016 Update, Company ReportProduct #: 497038
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved